Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with acquired immune deficiency syndrome and prevalence of virulent R. equi in soil collected from domestic animal farms in Chiang Mai, Thailand.
Takai S, Tharavichitkul P, Sasaki C, Onishi Y, Yamano S, Kakuda T, Tsubaki S, Trinarong C, Rojanasthien S, Sirimalaisuwan A, Tesaprateep T, Maneekarn N, Sirisanthana T, Kirikae T. Takai S, et al. Among authors: sasaki c. Am J Trop Med Hyg. 2002 Jan;66(1):52-5. doi: 10.4269/ajtmh.2002.66.52. Am J Trop Med Hyg. 2002. PMID: 12135268
Chromoblastomycosis in Brazil: A review of 450 published cases.
Barbosa LSP, Souza YRC, Sasaki CS, Santos DWD, Rossato L. Barbosa LSP, et al. Among authors: sasaki cs. Rev Soc Bras Med Trop. 2024 Nov 15;57:e00205-2024. doi: 10.1590/0037-8682-0132-2024. eCollection 2024. Rev Soc Bras Med Trop. 2024. PMID: 39570152 Free PMC article. Review.
Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor.
Hagihara S, Ishizawa K, Soga K, Honjo T, Takai S, Kawano Y, Kikuchi M, Nishidate A, Matsumoto F, Murase M, Hashimoto N, Sasaki C, Miyaguchi I, Okada O, Akashi T, Nakayama S, Ogasawara Y, Endo J. Hagihara S, et al. Among authors: sasaki c. Bioorg Med Chem Lett. 2024 Sep 1;109:129849. doi: 10.1016/j.bmcl.2024.129849. Epub 2024 Jun 12. Bioorg Med Chem Lett. 2024. PMID: 38876177
Discovery of a potent, orally available furopyridine derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor.
Hagihara S, Ishizawa K, Kikuchi M, Kawano Y, Nishidate A, Matsumoto F, Hashimoto N, Sasaki C, Miyaguchi I, Okada O, Akashi T, Nakayama S, Ogasawara Y, Endo J. Hagihara S, et al. Among authors: sasaki c. Bioorg Med Chem Lett. 2024 Sep 1;109:129848. doi: 10.1016/j.bmcl.2024.129848. Epub 2024 Jun 12. Bioorg Med Chem Lett. 2024. PMID: 38876176
A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103.
Sadahiro R, Hatta K, Yamaguchi T, Masanori E, Matsuda Y, Ogawa A, Iwata Y, Tokoro A, Nakahara R, Hirayama T, Yanai Y, Ogawa Y, Kayano A, Ariyoshi K, Oyamada S, Uchitomi Y, Akechi T, Yamamoto N, Okita N, Yorikane E, Shimada K, Furukawa T, Hashimoto H, Maeda M, Sato T, Sekimoto A, Sasaki C, Saito E, Uezono Y, Matsuoka H. Sadahiro R, et al. Among authors: sasaki c. Jpn J Clin Oncol. 2023 Aug 30;53(9):851-857. doi: 10.1093/jjco/hyad061. Jpn J Clin Oncol. 2023. PMID: 37340766 Free PMC article.
462 results